Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Return on Assets (2019 - 2025)

Cyclerion Therapeutics (CYCN) has disclosed Return on Assets for 7 consecutive years, with 0.42% as the latest value for Q3 2025.

  • For Q3 2025, Return on Assets changed N/A year-over-year to 0.42%; the TTM value through Sep 2025 reached 0.42%, changed N/A, while the annual FY2023 figure was 0.47%, 113.0% up from the prior year.
  • Return on Assets hit 0.42% in Q3 2025 for Cyclerion Therapeutics, down from 0.33% in the prior quarter.
  • Across five years, Return on Assets topped out at 1.26% in Q2 2024 and bottomed at 1.77% in Q1 2023.
  • Average Return on Assets over 5 years is 0.57%, with a median of 0.8% recorded in 2021.
  • Year-over-year, Return on Assets soared 267bps in 2024 and then crashed -158bps in 2025.
  • Cyclerion Therapeutics' Return on Assets stood at 0.87% in 2021, then tumbled by -89bps to 1.64% in 2022, then surged by 131bps to 0.51% in 2023, then surged by 145bps to 1.26% in 2024, then plummeted by -133bps to 0.42% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.42%, 0.33%, and 0.15% for Q3 2025, Q2 2025, and Q1 2025 respectively.